Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...

When I was assigned to write my first story about the blockbuster weight loss drug Ozempic in 2023, I groaned. Yes, weight ...

On a special episode (first released on July 16, 2025) of The Excerpt podcast: Despite the banning of hashtags that promote unhealthy weight loss content, the influence of SkinnyTok and thinspo ...

Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...

Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts say it’s a link that needs further study. Doctors have found a way to ...

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...